ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621200. A total of 31 filers reported holding ALLIQUA BIOMEDICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $28,000 | -31.7% | 76,706 | -6.9% | 0.00% | – |
| Q1 2017 | $41,000 | -14.6% | 82,393 | +0.9% | 0.00% | – |
| Q4 2016 | $48,000 | -23.8% | 81,619 | +0.6% | 0.00% | – |
| Q3 2016 | $63,000 | -30.0% | 81,103 | +0.2% | 0.00% | – |
| Q2 2016 | $90,000 | +36.4% | 80,974 | 0.0% | 0.00% | – |
| Q1 2016 | $66,000 | -61.8% | 80,974 | -0.2% | 0.00% | – |
| Q4 2015 | $173,000 | -32.4% | 81,103 | +0.3% | 0.00% | – |
| Q3 2015 | $256,000 | -31.6% | 80,845 | +13.7% | 0.00% | – |
| Q2 2015 | $374,000 | +61.9% | 71,100 | +59.6% | 0.00% | – |
| Q1 2015 | $231,000 | +26.2% | 44,559 | +29.0% | 0.00% | – |
| Q4 2014 | $183,000 | +9.6% | 34,541 | 0.0% | 0.00% | – |
| Q3 2014 | $167,000 | -11.6% | 34,541 | 0.0% | 0.00% | – |
| Q2 2014 | $189,000 | +85.3% | 34,541 | +182.8% | 0.00% | – |
| Q1 2014 | $102,000 | – | 12,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 583,026 | $653,000 | 0.28% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 1,206,127 | $1,351,000 | 0.17% |
| SABBY MANAGEMENT, LLC | 1,500,000 | $1,680,000 | 0.09% |
| Tekla Capital Management LLC | 1,650,000 | $1,848,000 | 0.08% |
| J. Goldman & Co LP | 540,000 | $605,000 | 0.03% |
| Chicago Partners Investment Group LLC | 6,453 | $7,000 | 0.00% |
| Edge Wealth Management LLC | 4,930 | $5,000 | 0.00% |
| Acrospire Investment Management LLC | 2,400 | $3,000 | 0.00% |
| US BANCORP \DE\ | 181,732 | $204,000 | 0.00% |
| Renaissance Technologies | 271,500 | $304,000 | 0.00% |